Clinical trial · Observational
Phenotyping Liver Cancer Registry
Large Scale Clinical Data Registry (CDR) to Accurately Identify the Specific Tumor Phenotypes to Better Diagnose and Predict Patient Outcome in HCC
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is the development of a content-based image retrieval (CBIR) platform, where validation studies will be conducted for liver disease subtyping and hepatocellular carcinoma (HCC) phenotyping on images for use as diagnostic and prognostic markers of outcome in conjunction with large scale data registries and advanced predictive machine learning methodologies. The proposed objectives will deliver one or more fit-for-purpose non-invasive imaging-based methodologies to evaluate the presence, activity and type of HCC in clinical practice.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Image features extraction and clustering | Device | — | UNRESOLVED |
| Phenotype signature database building | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patient with hepatocellular carcinoma
- description
- Phenotype signature database building Image features extraction and clustering
- interventionNames
- Device: Image features extraction and clustering
- Device: Phenotype signature database building
Primary outcomes (1)
- measure
- Specific tumor phenotypes
- timeFrame
- 2 years
- description
- accurately identify the specific tumor phenotypes to better diagnose and predict patient outcome in hepatocellular carcinoma
Secondary outcomes (4)
- measure
- Hepatocellular carcinoma detection and characterization
- timeFrame
- 2 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: Patients with visual liver disease who: * Have a lesion visualized on CT scans / MRI with histological confirmation (surgical resection, biopsy, transplant). * With a CT scan / MRI performed within 6 months prior to biopsy, surgical or transplant intervention. Exclusion Criteria: * Patients that had CT scans / MRI taken more than 6 months prior to surgical intervention
References
Publications (0)
Data not yet available